NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 33 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,796,292 | +24.9% | 14,928,000 | +25.2% | 0.00% | 0.0% |
Q2 2023 | $10,248,437 | +2.6% | 11,928,000 | +3.0% | 0.00% | 0.0% |
Q1 2023 | $9,991,490 | -55.8% | 11,578,000 | -54.6% | 0.00% | 0.0% |
Q4 2022 | $22,616,078 | +86.1% | 25,490,000 | +85.4% | 0.00% | 0.0% |
Q3 2022 | $12,152,000 | +10.2% | 13,750,000 | +8.7% | 0.00% | 0.0% |
Q2 2022 | $11,026,000 | -11.9% | 12,650,000 | -8.0% | 0.00% | 0.0% |
Q1 2022 | $12,519,000 | -22.9% | 13,750,000 | -21.9% | 0.00% | 0.0% |
Q4 2021 | $16,233,000 | – | 17,600,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 67,736,000 | $60,446,929 | 4.40% |
BRAIDWELL LP | 131,834,000 | $117,582,745 | 3.94% |
DeepCurrents Investment Group LLC | 38,391,000 | $34,368,176 | 1.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 16,861,000 | $14,946,863 | 0.93% |
Context Capital Management, LLC | 12,489 | $11,139 | 0.82% |
WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $68,630,367 | 0.71% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,113,250 | 0.47% |
Aequim Alternative Investments LP | 18,000,000 | $16,054,200 | 0.44% |
Ionic Capital Management LLC | 2,000,000 | $1,781,555 | 0.42% |
Verition Fund Management LLC | 27,771,000 | $24,768,955 | 0.39% |